AXSM Axsome Therapeutics, Inc. Stock Quote

AXSM [NASD]

Index	-	P/E	-	EPS (ttm)	-3.72	Insider Own	0.30%	Shs Outstand	38.32M	Perf Week	13.44%
Market Cap	1.23B	Forward P/E	-	EPS next Y	-2.72	Insider Trans	3.52%	Shs Float	30.83M	Perf Month	-20.08%
Income	-140.80M	PEG	-	EPS next Q	-1.17	Inst Own	50.40%	Short Float	14.66%	Perf Quarter	7.03%
Sales	-	P/S	-	EPS this Y	-25.30%	Inst Trans	3.60%	Short Ratio	4.23	Perf Half Y	-11.07%
Book/sh	0.38	P/B	83.29	EPS next Y	39.20%	ROA	-129.10%	Target Price	81.21	Perf Year	-42.84%
Cash/sh	2.19	P/C	14.48	EPS next 5Y	-	ROE	-389.70%	52W Range	19.38 - 74.10	Perf YTD	-16.23%
Dividend	-	P/FCF	-	EPS past 5Y	-19.50%	ROI	-	52W High	-60.64%	Beta	2.44
Dividend %	-	Quick Ratio	3.50	Sales past 5Y	-	Gross Margin	-	52W Low	50.51%	ATR	3.51
Employees	108	Current Ratio	3.50	Sales Q/Q	-	Oper. Margin	-	RSI (14)	44.37	Volatility	9.98% 10.25%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-32.30%	Profit Margin	-	Rel Volume	0.73	Prev Close	31.65
Shortable	Yes	LT Debt/Eq	3.35	Earnings	May 02 BMO	Payout	-	Avg Volume	1.07M	Price	29.17
Recom	1.80	SMA20	-6.44%	SMA50	-17.16%	SMA200	-11.45%	Volume	268,196	Change	-7.84%

Aug-10-21

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$105 → $34

Jun-10-21

Initiated

Berenberg

Buy

$112

Jan-08-21

Initiated

Jefferies

Buy

$129

Dec-16-20

Initiated

Mizuho

Buy

$120

Sep-29-20

Initiated

BofA Securities

Underperform

$66

Sep-10-20

Initiated

Morgan Stanley

Overweight

$102

Apr-28-20

Reiterated

H.C. Wainwright

Buy

$200 → $210

Apr-14-20

Initiated

Cowen

Outperform

$95

Dec-30-19

Reiterated

H.C. Wainwright

Buy

$170 → $200

Dec-17-19

Reiterated

H.C. Wainwright

Buy

$30 → $170

Dec-16-19

Reiterated

Guggenheim

Buy

$65 → $158

Oct-16-19

Initiated

Guggenheim

Buy

$48

Sep-18-19

Initiated

William Blair

Outperform

May-28-19

Initiated

SunTrust

Buy

May-23-19

Reiterated

H.C. Wainwright

Buy

$23 → $30

Apr-08-19

Initiated

SVB Leerink

Outperform

$25

Mar-15-19

Reiterated

H.C. Wainwright

Buy

$15 → $18

Oct-03-16

Resumed

Brean Capital

Buy

Dec-15-15

Initiated

Cantor Fitzgerald

Buy

Dec-14-15

Initiated

Ladenburg Thalmann

Buy

May-18-22 11:23AM	2 Under-the-Radar Biotech Stocks to Buy in 2022 Motley Fool -7.30%
07:00AM	Axsome Therapeutics Announces Publication of Pivotal ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder in The American Journal of Psychiatry PR Newswire
May-16-22 08:30AM	2 Biotech Stocks That Could Go Parabolic Motley Fool +10.47%
07:00AM	Axsome Therapeutics Supports the National Alliance on Mental Illness (NAMI) to Recognize Mental Health Awareness Month PR Newswire
May-14-22 06:15AM	Is This Biotech a Safe Stock to Buy? Motley Fool
May-13-22 04:00PM	My Favorite Biotech Motley Fool +10.10%
May-11-22 07:59AM	Axsome Therapeutics, Inc. (NASDAQ:AXSM) drops to US$1.1b and insiders who purchased earlier this year lose another US$77k Simply Wall St. -11.95%
May-09-22 05:46PM	Why Axsome Therapeutics Stock Got Mashed on Monday Motley Fool -10.06%
08:57AM	Axsome Therapeutics Completes U.S. Acquisition of Sunosi® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea GlobeNewswire
07:00AM	Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics PR Newswire
May-06-22 12:17PM	Axsome Shares Sink After Canceling Broker Conference: Morgan Stanley Investing.com -18.84%
May-03-22 10:49AM	Why Axsome (AXSM) is Up 7% Despite Wider-Than-Expected Q1 Loss Zacks +5.29%
May-02-22 03:00PM	Axsome Therapeutics (AXSM) Q1 2022 Earnings Call Transcript Motley Fool +7.21%
09:20AM	As Expected, FDA Rejects Axsome Therapeutics' Migraine Candidate Benzinga
07:05AM	Axsome Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update PR Newswire
07:00AM	Axsome Therapeutics Receives FDA Complete Response Letter for New Drug Application for AXS-07 for the Acute Treatment of Migraine PR Newswire
Apr-27-22 12:44PM	Biotech Stock Roundup: GILD's COVID-19 Drug Update, AXSM Down on Regulatory News Zacks
Apr-25-22 04:07PM	Axsome Therapeutics' Good Fortune Reverses As Its Migraine Drug Hits A Hurdle Investor's Business Daily -21.99%
10:49AM	Axsome Poised To Receive FDA Rejection For Its Migraine Candidate, Shares Fall Benzinga
07:00AM	Axsome Therapeutics to Report First Quarter 2022 Financial Results on May 2, 2022 PR Newswire
Apr-22-22 04:00PM	The FDA Will Soon Give These 3 Healthcare Companies the Green Light Motley Fool
11:15AM	Why This Stock Could Double Your Money in 2022 Motley Fool
Apr-20-22 10:49AM	Axsome (AXSM) Surges on Potential Approval for AXS-05 Soon Zacks +5.18%
Apr-19-22 04:13PM	Axsome Therapeutics Stock Rockets As Its First FDA Approval Looks Imminent Investor's Business Daily +25.14%
10:43AM	Why Axsome Therapeutics Is Jumping Higher on Tuesday Motley Fool
Apr-07-22 12:05PM	Axsome Therapeutics Stock Sees Relative Strength Rating Jump To 92 Investor's Business Daily -5.39%
Apr-01-22 09:00PM	3 CEOs to Invest In Motley Fool +6.09%
06:26PM	When Will Axsome Therapeutics, Inc. (NASDAQ:AXSM) Breakeven? Simply Wall St.
Mar-30-22 01:29PM	Biotech Stock Roundup: AXSM to Acquire JAZZ's Drug, IGMS Up on SNY Deal & More Zacks
Mar-29-22 06:19PM	Why Axsome Therapeutics Crushed the Market Again Today Motley Fool +11.96%
10:48AM	Axsome (AXSM) to Acquire Jazz's Sleep Disorder Drug, Sunosi Zacks
Mar-28-22 05:36PM	Why Axsome Therapeutics Stock Climbed 11.1% on Monday Motley Fool
06:00AM	Axsome Therapeutics to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsomes Leadership in Neuroscience GlobeNewswire
Mar-11-22 07:00AM	Axsome Therapeutics to Participate in the 1st Annual Needham Virtual Neuroscience Forum GlobeNewswire
Mar-06-22 07:04AM	3 Biotech Stocks That Can Make You Richer in March (and Beyond) Motley Fool
Mar-03-22 11:03AM	Intercept (ICPT) Q4 Earnings & Sales Beat, Ocaliva in Focus Zacks
Mar-02-22 11:16AM	Axsome (AXSM) Posts Narrower-Than-Expected Q4 Loss Zacks
10:12AM	Horizon (HZNP) Q4 Earnings Beat Estimates, Revenues Rise Y/Y Zacks
07:00AM	Axsome Therapeutics to Present at the Cowen 42nd Annual Health Care Conference GlobeNewswire
Mar-01-22 02:13PM	Why Axsome Therapeutics Stock Is Bolting Higher Today Motley Fool +10.21%
10:23AM	This Stock Could Soar by 195%, According to Wall Street Motley Fool
07:00AM	Axsome Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update GlobeNewswire
Feb-28-22 10:00AM	Drug/Biotech Stocks' Q4 Earnings on Mar 1: PRGO, JAZZ & More Zacks
Feb-18-22 11:50AM	Bristol Myers' (BMY) Breyanzi sBLA Gets FDA's Priority Review Zacks
Feb-15-22 07:00AM	Axsome Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022 GlobeNewswire +8.17%
Feb-11-22 07:00AM	Axsome Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-10-22 10:00AM	My Top High-Conviction Home Run Stock Motley Fool
Feb-09-22 12:01PM	Deciphera (DCPH) Q4 Loss Wider Than Expected, Revenues Beat Zacks +5.80%
Feb-08-22 09:09AM	Catalyst's (CPRX) Stock Up on 2022 Guidance for Firdapse Zacks
Feb-04-22 12:00PM	Viatris (VTRS) Gets FDA Nod for Generic Drug in Dry Eye Disease Zacks +6.22%
Jan-28-22 03:36PM	Epizyme (EPZM) Stock Dives on Public Offering of Common Stock Zacks +8.13%
Jan-26-22 10:00AM	2 Biotech Stocks That Could Be 10-Baggers in 2022 Motley Fool
Jan-18-22 06:55PM	Why Axsome Therapeutics Climbed Today While the Market Fell Motley Fool +5.52%
05:38PM	First Midwest Bank Trust Division Buys Axsome Therapeutics Inc, PROSHARES TRUST, iShares ... GuruFocus.com
11:00AM	Buy These Stocks If You Want 126% to 206% Returns, Says Wall Street Motley Fool
Jan-17-22 10:00AM	Down 19% in 4 Weeks, Here's Why Axsome (AXSM) Looks Ripe for a Turnaround Zacks
Jan-09-22 10:30AM	My 3 Top Biopharma Stock Picks for 2022 Motley Fool
Jan-07-22 08:32AM	Implied Volatility Surging for Axsome Therapeutics (AXSM) Stock Options Zacks
Dec-26-21 09:31AM	3 Biotech Stocks That Sank in 2021 but Could Soar in 2022 Motley Fool
Dec-16-21 04:38PM	Invesco Main Street Small Cap Fund Buys Chesapeake Energy Corp, Paycor HCM Inc, Acadia ... GuruFocus.com
Dec-15-21 12:38AM	Royce Capital Fund Buys Thryv Holdings Inc, Barnes & Noble Education Inc, Fossil Group Inc, ... GuruFocus.com +6.74%
Dec-13-21 04:38PM	Invesco V.I. Main Street Small Cap Fund Buys Chesapeake Energy Corp, Paycor HCM Inc, Acadia ... GuruFocus.com
Dec-07-21 10:00AM	8 Beaten-Down Pharmaceutical Stocks That Could Skyrocket In 2022 Motley Fool
Dec-03-21 08:36AM	Implied Volatility Surging for Axsome (AXSM) Stock Options Zacks
Dec-02-21 06:15PM	Why Axsome Therapeutics Stock Took a Step Backwards This Week Motley Fool
Nov-25-21 05:57AM	3 Biotech Stocks That Can Double Your Money, According to Wall Street Motley Fool
04:11AM	Insiders who bought into Axsome Therapeutics, Inc. (NASDAQ:AXSM) earlier this year might wish they'd invested more as stock gained 9.8% Simply Wall St.
Nov-24-21 06:25AM	2 Top Biotech Stocks Ready for a Bull Run Motley Fool
Nov-10-21 10:18AM	How Much Upside is Left in Axsome (AXSM)? Wall Street Analysts Think 144% Zacks -6.38%
Nov-09-21 10:04AM	Axsome (AXSM) Q3 Earnings Top, Pre-Launch Activities Continue Zacks -5.97%
Nov-08-21 05:30PM	Axsome Therapeutics, inc (AXSM) Q3 2021 Earnings Call Transcript Motley Fool +7.86%
12:37PM	Why Axsome Therapeutics Stock Is Rising Today Motley Fool
07:00AM	Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
Oct-20-21 07:00AM	Axsome Therapeutics to Report Third Quarter 2021 Financial Results on November 8, 2021 GlobeNewswire
Oct-18-21 07:00AM	Axsome Therapeutics Expands Term Loan Facility with Hercules Capital to $300 Million GlobeNewswire
Oct-17-21 06:21AM	3 Biotech Stocks That Could Rise 90% or More, According to Wall Street Motley Fool
Oct-15-21 10:00AM	Why Axsome Therapeutics Stock Rocketed Higher This Week Motley Fool
Oct-14-21 10:30AM	1 Beaten-Down Stock With 10X Potential Motley Fool
Oct-06-21 10:45AM	Why Axsome Therapeutics Stock Caught Fire in September Motley Fool
Sep-29-21 10:03PM	SHAREHOLDER ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors with Losses Over $100K to Inquire About Class Action Investigation - AXSM PR Newswire
Sep-25-21 07:00AM	2 Best Biotech Stocks to Buy Right Now Motley Fool
Sep-24-21 01:45PM	Do Options Traders Know Something About Axsome (AXSM) Stock We Don't? Zacks
Sep-23-21 06:43AM	Why Wall Street Thinks This Biotech Stock Can Triple Your Money Motley Fool +6.70%
Sep-17-21 10:05AM	Axsome (AXSM) Begins Late-Stage Sleep Disorder Study on AXS-12 Zacks
Sep-16-21 07:00AM	Axsome Therapeutics Initiates SYMPHONY Phase 3 Trial of AXS-12 in Narcolepsy GlobeNewswire
Sep-15-21 10:26AM	Axsome's (AXSM) Migraine Drug AXS-07 NDA Gets FDA Acceptance Zacks +5.92%
Sep-14-21 07:00AM	Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-07 for the Acute Treatment of Migraine GlobeNewswire
Sep-08-21 02:15PM	Why Axsome Therapeutics Stock Cratered in August Motley Fool
Sep-07-21 05:00PM	3 Healthcare Stocks That Might Skyrocket When COVID Is Over Motley Fool
07:03AM	3 Biotech Stocks Wall Street Expects to Double Soon Motley Fool
Sep-05-21 09:55AM	Buy, Sell, or Hold Axsome Therapeutics Stock After Its FDA Approval Delay? Motley Fool
Sep-02-21 06:02AM	3 Biotech Stocks That Are Too Cheap to Ignore Motley Fool
Sep-01-21 02:42PM	Here's Why Axsome Therapeutics Stock Is Surging Today Motley Fool +7.90%
Aug-27-21 10:40AM	Which Biotech Stock Will Shock the Market in 2022? Motley Fool
Aug-24-21 11:37AM	Axsome's (AXSM) Stock Up Despite FDA Delay on Depression Drug Zacks
09:41AM	Axsome Might Still be Awesome for Your Portfolio TipRanks
Aug-23-21 12:15PM	Why Axsome Therapeutics Stock Is Jumping Today Motley Fool +14.98%
08:28AM	Why Is Axsome Therapeutics (AXSM) Stock Shooting Higher On Monday? Benzinga
06:11AM	U.S. FDA unable to complete review of Axsome depression drug by target action date Reuters
06:00AM	Axsome Therapeutics Provides Update on the New Drug Application for AXS-05 for the Treatment of Major Depressive Disorder GlobeNewswire

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Coleman Mark	Director	Mar 15	Option Exercise	1.30	3,496	4,545	7,596	Mar 17 07:05 AM
JEFFS ROGER	Director	Nov 19	Buy	37.30	3,950	147,350	120,756	Nov 23 07:30 AM
Pizzie Nick	CHIEF FINANCIAL OFFICER	Nov 18	Buy	34.97	428	14,968	201	Nov 22 07:31 AM
Pizzie Nick	CHIEF FINANCIAL OFFICER	Nov 18	Buy	35.50	527	18,708	41,789	Nov 22 07:31 AM
Coleman Mark	Director	Nov 18	Buy	35.09	1,430	50,181	422,428	Nov 22 07:30 AM
Saad Mark E	Director	Nov 17	Buy	34.41	300	10,324	100	Nov 19 07:30 AM
Saad Mark E	Director	Nov 17	Buy	34.53	3,000	103,597	10,002	Nov 19 07:30 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience